Objective: The purpose of this study was to determine predictors of worsening insulin sensitivity in postmenopausal women. Study design: Seventy- one nonobese postmenopausal women were assigned randomly to receive hor...
Objective: This study was undertaken to compare resource use outcomes for participants in the Medicine or Surgery (Ms)- randomized trial. Study design: In a randomized controlled trial, we compared resources used duri...
Objective. The ambition of this article is to detail and to explain the methodology of the study named MISSION (Menopause: breast cancer risk, morbidity and prevalence). The aims of MISSION are to determine the preval...
Conjugated equine estrogen alone or combined with medroxyprogesterone acetate lowered homocysteine levels in postmenopausal women. Regardless of the dosage of progestin used, there was no impact on homocysteine metabo...
Objective: To investigate the effects of hormone therapy, estrogen therapy and tibolone on markers of apoptosis including bcl-2, and bax and cyclin D 1 expression in postmenopausal vaginal epithelium. Study design: Th...
Objective: The main objectives of this study were to investigate whether [1] s ubcutaneous (SC) administration of pulsatile gonadotropin-releasing hormone (Gn RH) decreases the increased levels of luteinizing hormone ...
The purpose of this clinical trial was to evaluate the effect of estrogen supplementation on bone mineral density in adolescent girls who received depot medroxyprogesterone acetate for contraception. One hundred twent...
We studied the impact of progestin dose on this risk. The pattern and number of days per month that progestin is given in postmenopausal combined hormone therapy appears to affect endometrial cancer risk. We assessed ...